The products to be marketed under the joint brand AvestaAyurVAID
Avesthagen Limited (Avesthagen) and Apollo AyurVAID, a unit of Kerala First Health Services Private Limited, an Apollo Hospitals Group Company, announced their strategic partnership to design, validate, manufacture, and market a range of breakthrough, scientifically validated medical-foods and dietary supplements, aimed at setting a new industry benchmark for quality, efficacy, and safety.
The products to be marketed under the joint brand “AvestaAyurVAID” aim to promote the integration of medical nutrition with Ayurvedic principles for a new generation of consumer and prescription health products. They shall address specific dietary management of a specific disease or syndrome or disease state for which distinctive nutritional requirements have been established by systematic medical evaluation.
Natural bioactives based on promising Ayurveda botanical candidates shall be developed and validated through Avesthagen’s ADePt, a proprietary bioactive discovery engine, and MetaGrid, an exclusive bioactive testing methodology. The collaboration shall emphasise rigorous scientific and clinical validation to ensure industry-leading product safety and efficacy profile.
Avesthagen and Apollo AyurVAID shall synergistically combine their expertise, and knowledge to design, manufacture and market precision medical foods utilising innovative strategies that enhance patient care, promote holistic wellness and advance the field of integrative medicine and modern medical nutrition.